Synapse - Works

Results (5608)

A phase I dose-escalation and expansion study of telaglenastat in patients with advanced or metastatic solid tumors

Journal Article

Harding, J. J.; Telli, M.; Munster, P.; Voss, M. H.; Infante, J. R.; DeMichele, A.; Dunphy, M.; Le, M. H.; Molineaux, C.; Orford, K.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

NECTIN4 heterogeneity and molecular diversity in bladder cancers: Deconstructing the activity of an antibody-drug conjugate

Editorial

Teo, M. Y.; Rosenberg, J. E.
Clinical Cancer Research (2021)

Fulltext@MSK | Save

A phase Ib study of atezolizumab with radium-223 dichloride in men with metastatic castration-resistant prostate cancer

Journal Article

Fong, L.; Morris, M. J.; Sartor, O.; Higano, C. S.; Pagliaro, L.; Alva, A.; Appleman, L. J.; Tan, W.; Vaishampayan, U.; Porcu, R.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE)

Journal Article

Swami, N.; Hwang, W. L.; Guo, J. A.; Hoffman, H.; Abramowitz, M. C.; Elbakouny, Z.; Beltran, H.; Chipidza, F.; Choueiri, T.; Dal Pra, A.; more...
Cancer Genetics (2021)

Fulltext@MSK | Save

Health-related quality of life with adjuvant nivolumab vs. placebo after radical resection for high-risk muscle-invasive urothelial carcinoma: Results from the phase 3 checkmate 274 trial

Meeting Abstract

Gschwend, J. E.; Bajorin, D.; Galsky, M.; Broughton, E.; Braverman, J.; Koon, H.; Maira-Arce, M.; Hamilton, M.; Shi, L.; Guo, S.; more...
European Urology (2021)

Fulltext@MSK | Save

Neutrophil-to-lymphocyte ratio in unclassified renal cell carcinoma is associated with clinical outcome and varies between genomic subgroups

Meeting Abstract

Marcon, J.; Di Natale, R. G.; Weng, S.; Ghanaat, M.; Silagy, A. W.; Mano, R.; Blum, K. A.; Attalla, K.; Reznik, E.; Carlo, M. I.; more...
European Urology (2021)

Fulltext@MSK | Save

IMmotion151: Updated overall survival (OS) and exploratory analysis of the association of gene expression and clinical outcomes with atezolizumab plus bevacizumab vs sunitinib in patients with locally advanced or metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Rini, B. I.; Atkins, M. B.; Escudier, B.; Powles, T.; McDermott, D. F.; Alekseev, B. Y.; Lee, J. L.; Stroyakovskiy, D.; Suarez Rodriguez, C.; De Giorgi, U.; more...
Cancer Research (2021)

Fulltext@MSK | Save

Large-scale genome-wide association study identifies multiple novel germline susceptibility variants associated with bladder cancer risk

Meeting Abstract

Koutros, S.; Kiemeney, L. A.; Milne, R. L.; Ye, Y.; Joseph, V.; Figueroa, J.; Chatterjee, N.; Giles, G. G.; Hildebrandt, M. A.; Dyrskjot, L.; more...
Cancer Research (2021)

Fulltext@MSK | Save

A phase 1b/2 umbrella study of investigational immune and targeted combination therapies for patients with advanced renal cell carcinoma (RCC) who progressed on PD-1/L1 and VEGF inhibitors

Meeting Abstract

Hammers, H.; Choueiri, T.; Plimack, E.; Rini, B.; Motzer, R.; Yin, L.; Perini, R.; Willemann-Rogerio, J.; Albiges, L.
Cancer Research (2021)

Fulltext@MSK | Save

Urothelial cancer-GENOmic analysis to improve patient outcomes and research (UC-GENOME): A bladder cancer advocacy network (BCAN) led collaborative research study

Meeting Abstract

Damrauer, J. S.; Klomp, J.; Beck, W.; Zhou, M.; Plimack, E.; Galsky, M.; Grivas, P.; Hahn, N.; O'Donnell, P.; Iyer, G.; more...
Cancer Research (2021)

Fulltext@MSK | Save